Ondoa, P., Vereecken, C., Asahchop, E. L., Litzroth, A., Diallo, A., Fransen, K., ...
The measurement of CD4 counts and viral loads on a single instrument such as an affordable flow cytometer could considerably reduce the cost related to the follow-up of antiretroviral therapy in...
Ruelle, J., Roman, F., Vandenbroucke, A. T., Lambert, C., Fransen, K., Echahidi, F., ...
BACKGROUND: Guidelines established for the treatment of HIV-1 infection and genotype interpretation do not apply for HIV-2. Data about antiretroviral (ARV) drug efficacy and resistance mutations is...
Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., ...
This study is the first prospective study to assess the prevalence, epidemiology, and risk factors of HIV-1 drug resistance in newly diagnosed HIV-infected patients in Belgium. In January 2003 it was...
Stevens, W., Sherman, G., Downing, R., Parsons, L. M., Ou, C. Y., Crowley, S., ...
A two day meeting hosted by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) was held in May 2006 in Entebbe, Uganda to review the laboratory...
Steyaert, S., Heyndrickx, L., Verhoye, L., Vermoesen, T., Donners, H., Fransen, K., ...
Although a limited number of HIV-infected patients have broadly neutralizing antibodies, it has not been examined whether these antibodies can protect against infection with primary virus in vivo....
Steyaert, S., Verhoye, L., Beirnaert, E., Donners, H., Fransen, K., Heyndrickx, L., ...
The intrasplenic injection of human peripheral blood mononuclear cells (PBMCs) into severely immune deficient NOD/SCID mice, causes a massive and transient dominant expansion of human B cells in the...
Garc¡a Ribas, S., Heyndrickx, L., Ondoa, P., Fransen, K.
This article describes the performance of the two protease sequencing modules available in the Trugene HIV-1 genotyping Kit on a sample population with a high prevalence of HIV-1 non-B subtypes...
Ondoa, P., Dieye, T. N., Vereecken, C., Camara, M., Diallo, A. A., Fransen, K., ...
Not the final published version
Tavernier, A., Jennes, W., Fransen, K., De Roo, A., Kestens, L.
Not the final published version
Pediatric human immunodeficiency virus screening in an African district hospital (2005)
DE BAETS, AJ, EDIDI, BS, KASALI, MJ, BEELAERT, G, SCHROOTEN, W, LITZROTH, A, ...
Colebunders, R., Hodossy, B., Burger, D., Daems, T., Roelens, K., Coppens, M., ...
Not the final published version
Pediatric human immunodeficiency virus screening in an African district hospital (2005)
De Baets, A. J., Edidi, B. S., Kasali, M. J., Beelaert, G., Schrooten, W., Litzroth, A., ...
In order to evaluate alternative tests and strategies to simplify pediatric human immunodeficiency virus (HIV) screening at the district hospital level, a cross-sectional exploratory study was...
Njai, H. F., Lewi, P. J., Janssen, C. G. M., Garcia, S., Fransen, K., Kestens, L., ...
This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might...
Florence, E, Van Esbroeck, M, Fransen, K, Desmet, P, Colebunders, R, Kestens, L, ...
Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...
Florence, E, Van Esbroeck, M, Fransen, K, Desmet, P, Colebunders, R, Kestens, L, ...
Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...
Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Wit, S., Florence, E., ...
Not the final published version
Florence, E., Dreezen, C., Schrooten, W., Van Esbroeck, M., Kestens, L., Fransen, K., ...
Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...
Schrooten, W., Florence, E., Dreezen, C., Van Esbroeck, M., Fransen, K., Alonso, A., ...
Our objective was to study the evolution of CD4 cell count five years after starting highly active antiretroviral treatment (HAART) in a clinical setting. The study was performed at the HIV...
Jennes, W., Vereecken, C., Fransen, K., De Roo, A., Kestens, L.
The protective role of beta-chemokines in HIV infection and disease remains controversial. Contradictory findings have been reported possibly as the result of different beta-chemokine detection...
Van Herrewege, Y., Michiels, J., Van Roey, J., Fransen, K., Kestens, L., Balzarini, J., ...
An in vitro model of monocyte-derived dendritic cells (MO-DC) and CD4(+) T cells, representing the primary targets of sexual human immunodeficiency virus (HIV) transmission, was used to evaluate the...
Van Herrewege, Y., Vanham, G., Michiels, J., Fransen, K., Kestens, L., Andries, K., ...
An in vitro model of monocyte-derived dendritic cells (MO-DC) and CD4(+) T cells, representing the primary targets of sexual human immunodeficiency virus (HIV) transmission, was used to evaluate the...
Ziermann, R., Celis, L., Derdelinckx, I., Lambert, C., Veeck, J., Rizzo, M. G., ...
BACKGROUND: Resistance testing is increasingly accepted as a tool in guiding the selection of human immunodeficiency virus type 1 (HIV-1) antiretroviral therapy in HIV-1 infected individuals who fail...
Ribas, S G, Ondoa, P, Schüpbach, J, Fransen, K
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for...
Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Schouwer, K., De Wit, S., ...
In this study we evaluated the performance of the VERSANT HIV-1 Resistance Assays (LiPA) in detecting drug resistance in therapy-naive HIV-infected patients diagnosed in Belgium in 2000. We compared...
García Ribas, S., Ondoa, P., Schüpbach, J., Fransen, K.
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for...
Muwonga, J., Edidi, S., Atibu, L., Mama, N., Lepira, F., Tahiri, M., ...
Ondoa, P., Vereecken, C., Fransen, K., Colebunders, R., Heeney, J. L., ...
This study was undertaken to explain why chimpanzees infected with HIV-1 (human immunodeficiency virus type 1) or SIV(cpz) (simian immunodeficiency virus of chimpanzee) are relatively resistant to...
Role of baseline pol genotype in HIV-1 fitness evolution (2003)
Weber, J., Rangel, H. R., Chakraborty, B., Marotta, M. L., Valdez, H., Fransen, K., ...
Not the final published version
Florence, E., Dreezen, C., Desmet, P., Smets, E., Fransen, K., Vandercam, B., ...
This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might...
Beelaert, G., Vercauteren, G., Fransen, K., Mangelschots, M., De Rooy, M., Garc¡a Ribas, S., ...
To evaluate the performance of 22 assays for the detection of antibodies to HIV. Twenty-two assays for the combined detection of antibodies to HIV-1 and HIV-2, were evaluated on the same panel of...
Ondoa, P., Davis, D., Kestens, L., Vereecken, C., García Ribas, S., Fransen, K., ...
This study was undertaken to evaluate and compare the susceptibility of chimpanzee versus human peripheral blood mononuclear cells (PBMCs) to infection with SIVcpz and HIV-1 non-syncitium inducing...
Servais, J., Hainaut, M., Schmitz, V., Maes, P., Fransen, K., Vaira, D., ...
OBJECTIVE: To assess genotypic and phenotypic resistance testing in HIV-1-infected children failing a first protease inhibitor (PI) therapy. METHODS: In a multicenter observational study 21 children,...
Van Herrewege, Y., Penne, L., Vereecken, C., Fransen, K., Kestens, L., ...
Because prevention of heterosexual HIV transmission is not always possible, it is important to develop effective strategies of postexposure prophylaxis (PEP). Since in vivo comparison of drug potency...
Derdelinckx, Inge; U0034960, Maes, B, Schrooten, Yoeri; U0029701, Dewit, Sophie; U0052409, Florence, E, ...
Dreezen, C, Desmet, P, Smets, E, Fransen, K, Vandercam, B, ...
Objectives: To compare the efficacy, tolerability and safety of a ritonavir 400 mg/saquinavir hard gel fomulation 400 mg twice daily versus an indinavir 800 mg once every 8 In containing first-line...
Ondoa, P, Kestens, L, Davis, D, Vereecken, C, Willems, B, Fransen, K, ...
In a longitudinal study we address the hypothesis that resistance to disease progression in lentivirus-infected chimpanzees is related to potent non-cytotoxic suppression of virus replication. In a...
Quantitative assay for group M (subtype A-H) and group O HIV-1 RNA detection in plasma (2001)
Ernest, I., Alexandre, I., Zammatteo, N., Herman, M., Houbion, A., De Leener, F., ...
A quantitative HIV-1 test is described based on a competitive RT-PCR assay combined with a sandwich hybridization as a detection system. The internal RNA standard (IS) was designed specifically to be...
Evaluation of four HIV antigen tests (2001)
A direct comparison of different HIV antigen assays is very helpful in making an informed choice, not only for the testing laboratories but also for healthcare workers in the developing world who are...
Ondoa, P., Kestens, L., Davis, D., Vereecken, C., Willems, B., Fransen, K., ...
In a longitudinal study we address the hypothesis that resis tance to disease progression in lentivirus-infected chimpanzees is related to potent non-cytotoxic suppression of virus replication. In a...
Van Vaerenbergh, K., Debaisieux, L., De Cabooter, N., Declercq, C., Desmet, K., Fransen, K., ...
This is the author’s version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might...
Debaisieux, L, Fransen, K, Marissens, D, Miller, K, Vaira, D, ...
OBJECTIVE: In order to evaluate the interlaboratory variation of HIV-1 RNA measurements in plasma, the Belgian AIDS reference laboratories organized a blinded multicenter quality control study....
Vanham, G, Van Tendeloo, V, Willems, B, Penne, L, Kestens, L, Beirnaert, E, ...
During sexual transmission, HIV infects the mucosal dendritic cells and is transferred to CD4 T cells. Whether HIV variants of a particular genetic (sub)type or phenotype selectively infect dendritic...
HIV-1 genetic variability in Cameroon. (2000)
HEYNDRICKX, L, JANSSENS, W, NDUMBE, PM, VEREECKEN, K, COPPENS, S, DE HOUWER, K, ...
De Baar, M. P., Janssens, W., De Ronde, A., Fransen, K., Colebunders, R., Kestens, L., ...
HIV-1 group O viruses were first recognized as a distinct subgroup of HIV-1 with the isolation and characterization in 1990 of a virus (ANT70) from a woman (individual A) and her spouse (individual...
HIV-1 genetic variability in Cameroon [letter] (2000)
Heyndrickx, L., Janssens, W., Ndumbe, P. M., Vereecken, K., Coppens, S., De Houwer, K., ...
Not the final published version
Muyldermans, G., Debaisieux, L., Fransen, K., Marissens, D., Miller, K., Vaira, D., ...
The definitive version is available at www3.interscience.wiley.com
Vanham, G., Van Tendeloo, V., Willems, B., Penne, L., Kestens, L., Beirnaert, E., ...
During sexual transmission, HIV infects the mucosal dendritic cells and is transferred to CD4 T cells. Whether HIV variants of a particular genetic (sub)type or phenotype selectively infect dendritic...
Interpatient genetic variability of HIV-1 group O. (1999)
JANSSENS, W, HEYNDRICKX, L, NKENGASONG, J, BEIRNAERT, E, VEREECKEN, K, ...
Intrapatient variability of HIV type 1 group O ANT70 during a 10-Year follow-up (1999)
Janssens, W, Nkengasong, J, Heyndrickx, L, Vereecken, Karen; U0002243, Coppens, S, ...
HIV-1 ANT70 is the first HIV-1 group O virus isolate obtained from a 25-year-old Cameroonian woman, who seroconverted in March 1987, This individual has remained asymptomatic and clinically healthy...
Sequence note - HIV type 1 C2V3 env diversity among Belgian individuals (1998)
Heyndrickx, L, Janssens, W, Coppens, S, Vereecken, Karen; U0002243, Willems, B, Fransen, K, ...
Sequence note - HIV type 1 C2V3 env diversity among Belgian individuals. (1998)
HEYNDRICKX, L, JANSSENS, W, COPPENS, S, VEREECKEN, K, WILLEMS, B, FRANSEN, K, ...
Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. (1998)
NYAMBI, PN, BEIRNAERT, E, DAVIS, D, FRANSEN, K, HEYNDRICKX, L, ...
Fransen, K., Mortier, D., Heyndrickx, L., Verhofstede, Chris, Janssens, W.
Some new commercial methods for the extraction of viral RNA have been introduced recently. In addition to the study published previously (Verhofstede, C., Reniers, S., Van Wanzeele, F., Plum J.,...
Nkengasong, JN, Fransen, K, Willems, B, Karita, E, Vingerhoets, J, Kestens, L, ...
The pathogenic course (virologic, immunologic, and clinical changes) of infection due to human immunodeficiency virus type one (HIV-1) group O viruses is unknown at present. To address this issue,...
Genetic variability of HIV type 1 in Benin (1996)
Heyndrickx, L, Janssens, W, Alary, M, Fransen, K, Vereecken, Karen; U0002243, Coppens, S, ...
Isolation of HIV-1 RNA from plasma: Evaluation of eight different extraction methods. (1996)
Verhofstede, Chris, FRANSEN, K, MARISSENS, D, Verhelst, Rita, VANDERGROEN, G, LAUWERS, S, ...
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994 (1996)
Delaporte, Eric, Janssens, W., Peeters, Martine, Buvé, A., Dibanga, G., Perret, J.L., ...
Kok, W, Goubau, P, Fransen, K, Kievits, T, ...
The presence of HIV-1 RNA in the plasma and serum of European and African patients was monitored using RNA-polymerase chain reaction (RNA-PCR) and the new isothermal NASBA nucleic acid amplification...
Fransen, K, Debaisieux, L, Marissens, D, Sprecher, S, Vaira, D, ...
Eight Belgian AIDS Reference Laboratories established a multicentre quality control to evaluate the performance of their diagnostic human immunodeficiency virus type 1 (HIV-1) DNA polymerase chain...
Virologic and serologic characteristics of a natural chimpanzee lentivirus infection (1995)
WILLEMS, Betty, Peeters, M., Janssens, W., Vanden Haesevelde, M., Fransen, K., Heyndrickx, L., ...
Virologic and serologic characteristics of a natural chimpanzee lentivirus infection (1995)
WILLEMS, Betty, Peeters, M., Janssens, W., Vanden Haesevelde, M., Fransen, K., Heyndrickx, L., ...
RISK-FACTORS FOR MOTHER-TO-CHILD TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION. (1995)
BWAYO, J, Temmerman, Marleen, NYONGO, AO, FRANSEN, K, COPPENS, M, PIOT, P
Nyambi, P, Nkengasong, J, Peeters, M, Simon, F, Eberle, J, Jansens, W, ...
Zhong, P, Peeters, M, Janssens, W, Fransen, K, Heyndrickx, L, Vanham, G, ...
The relationship between the genetic variability in the V3 loop and the biological characteristics of 38 biological clones from 5 European and 7 African HIV-1 isolates belonging to 3 different...
Genetic and phylogenetic analysis of hiv type-1 in gabon (1995)
Janssens, W, Heyndrickx, L, Fransen, K, Delaporte, E, Peeters, M, Perret, Jl, ...
Biological phenotypes of hiv-1 subtype-a and subtype-b strains of diverse origins (1995)
Nkengasong, Jn, Peeters, M, Zhong, P, Willems, B, Janssens, W, Heyndrickx, L, ...
The identification of specific biologic phenotypic traits that can be correlated with different HIV-1 genetic subtypes was sought. The genetic subtypes were determined by either sequencing...
Nkengasong, Jn, Peeters, M, Ndumbe, P, Janssens, W, Willems, B, Fransen, K, ...
Objectives: To determine the neutralizing antibody patterns to HIV-1(ANT70) (ANT70) and HIV-1(IIIB)(IIIB) in human sera obtained from HIV-1-infected individuals from different African countries and...
Fransen, K, Peeters, M, De Beenhouwer, H, Piot, P
A semiquantitative PCR technique for detecting human immunodeficiency virus type 1 (HIV-1) RNA in plasma was compared with quantitative viral culture and p24 antigen detection in plasma. Ninety-three...
Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire (1994)
Peeters, M, Fransen, K, Gershy-Damet, G M, Willems, B, Koffi, K, Coulibaly, M, ...
Dual seroreactivity to the human immunodeficiency virus (HIV) types 1 and 2 is common in Côte d'Ivoire. To assess whether dual infection is the reason for dual seroreactivity, different methods for...
GENETIC-VARIABILITY OF HIV TYPE-1 IN KENYA. (1994)
JANSSENS, W, HEYNDRICKX, L, FRANSEN, K, Temmerman, Marleen, LEONAERS, A, IVENS, T, ...
Janssens, W, Fransen, K, Brandful, J, Heyndrickx, L, Koffi, K, ...
Objective: To search for the presence of SIV in sooty mangabeys and other monkey species in Cote d'Ivoire, West Africa, and to compare viral isolates with HIV-2 strains from the same region.
Genetic and antigenic variability of hiv type-1 in brazil (1994)
Janssens, W, Heyndrickx, L, Motte, J, Fransen, K, Peeters, M, ...
Six Brazilian strains of human immunodeficiency virus type 1 (HIV-1) were isolated from infected individuals residing in different regions of Brazil between 1987 and 1989. Phylogenetic analysis based...
Genetic and phylogenetic analysis of env subtypes G and H in Central Africa (1994)
Janssens, W., Heyndrickx, L., Fransen, K., Motte, J., Peeters, Martine, Nkengasong, J.N., ...
McCutchan, F E, Peeters, M, Brennan, T P, Sanders-Buell, E, Eddy, G A, ...
OBJECTIVE: To determine the extent of genetic variation among internationally collected HIV-1 isolates, to analyse phylogenetic relationships and the geographic distribution of different variants....
Gershy-Damet, G M, Fransen, K, Koffi, K, Coulibaly, M, Delaporte, E, ...
Dual serological reactivity to the human immunodeficiency virus (HIV) types 1 and 2 is common in Côte d'Ivoire. To assess whether dual infection is the reason for dual seropositivity we sought HIV-1...
Genetic comparison of HIV-1 isolates from Africa, Europe, and North America (1992)
McCutchan, F, Peeters, M, Fransen, K, Piot, P, ...
Henry M. Jackson Foundation, Rockville, MD 20850.
Fransen, K, Delaporte, E, Gershy-Damet, G M, Kestens, L, ...
OBJECTIVE: To assess the prevalence of infection with simian immunodeficiency virus (SIV) isolate cpz, a lentivirus closely related to HIV-1, in chimpanzees, and to obtain new SIVcpz isolates....
Further characterization of 2 immunodeficiency virus isolates from wild captured chimpanzees (1991)
Fransen, K, Delaporte, E, Vandenhaesevelde, M, Saman, E, Piot, P, ...
Multivariate analysis of human immunodeficiency virus type 1 neutralization data.
Nyambi, P N, Nkengasong, J, Lewi, P, Andries, K, Janssens, W, Fransen, K, ...
We report on the use of spectral map analysis of the inter- and intraclade neutralization data of 14 sera of human immunodeficiency virus type 1 (HIV-1)-infected individuals and 16 primary isolates,...
Nyambi, P N, Lewi, P, Peeters, M, Janssens, W, Heyndrickx, L, Fransen, K, ...
Here we report on the use of spectral map analysis of time-paired sequential neutralization data of 11 serum samples of a chimpanzee naturally infected with a simian immunodeficiency virus...
Van Kerckhoven, I, Fransen, K, Peeters, M, De Beenhouwer, H, Piot, P
A semiquantitative PCR technique for detecting human immunodeficiency virus type 1 (HIV-1) RNA in plasma was compared with quantitative viral culture and p24 antigen detection in plasma. Ninety-three...
Nyambi, P N, Fransen, K, De Beenhouwer, H, Chomba, E N, Temmerman, M, Ndinya-Achola, J O, ...
The human immunodeficiency virus type 1 (HIV-1) DNA PCR results of 94 dried blood spot (DBS) samples on filter paper and corresponding venous blood in EDTA obtained from infants born to...
Pediatric Human Immunodeficiency Virus Screening in an African District Hospital
De Baets, A. J., Edidi, B. S., Kasali, M. J., Beelaert, G., Schrooten, W., Litzroth, A., ...
In order to evaluate alternative tests and strategies to simplify pediatric human immunodeficiency virus (HIV) screening at the district hospital level, a cross-sectional exploratory study was...
Multivariate analysis of human immunodeficiency virus type 1 neutralization data.
Nyambi, P N, Nkengasong, J, Lewi, P, Andries, K, Janssens, W, Fransen, K, ...
We report on the use of spectral map analysis of the inter- and intraclade neutralization data of 14 sera of human immunodeficiency virus type 1 (HIV-1)-infected individuals and 16 primary isolates,...
Nyambi, P N, Lewi, P, Peeters, M, Janssens, W, Heyndrickx, L, Fransen, K, ...
Here we report on the use of spectral map analysis of time-paired sequential neutralization data of 11 serum samples of a chimpanzee naturally infected with a simian immunodeficiency virus...
Van Kerckhoven, I, Fransen, K, Peeters, M, De Beenhouwer, H, Piot, P
A semiquantitative PCR technique for detecting human immunodeficiency virus type 1 (HIV-1) RNA in plasma was compared with quantitative viral culture and p24 antigen detection in plasma. Ninety-three...
Nyambi, P N, Fransen, K, De Beenhouwer, H, Chomba, E N, Temmerman, M, Ndinya-Achola, J O, ...
The human immunodeficiency virus type 1 (HIV-1) DNA PCR results of 94 dried blood spot (DBS) samples on filter paper and corresponding venous blood in EDTA obtained from infants born to...
Pediatric Human Immunodeficiency Virus Screening in an African District Hospital
De Baets, A. J., Edidi, B. S., Kasali, M. J., Beelaert, G., Schrooten, W., Litzroth, A., ...
In order to evaluate alternative tests and strategies to simplify pediatric human immunodeficiency virus (HIV) screening at the district hospital level, a cross-sectional exploratory study was...
Stevens, W, Downing, R, Parsons, L.M, Crowley, S, ...
A two day meeting hosted by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) was held in May 2006 in Entebbe, Uganda to review the laboratory...